{
  "completed": true,
  "status": "completed_original_source_reconciliation",
  "provider_mode": "Consensus Pro signed-in browser; observed output and citation link mappings",
  "queries": [
    "https://consensus.app/search/adiposity-and-early-onset-colorectal-cancer/DfzQlwL2RFObTeFSeehk8Q/"
  ],
  "query_record_note": "Exact provider question/response retained privately in its retrieval receipt.",
  "primary_comparison_count": 8,
  "primary_comparisons": [
    {
      "pmid": "41422343",
      "doi": "10.1038/s41416-025-03303-y",
      "source_type": "primary study report",
      "study_group": "PMID41422343",
      "access_depth": "full_text_partial",
      "consensus_aspect": "Age threshold and male colon estimate",
      "result_comparison": "Consensus cites the pooled European cohort for a55percent male colon-risk increase per five BMI units while discussing a before50 proposition. Original Methods explicitly define early onset as before55 to increase power; Results confirm HR1.55 for male colon cancer, female BMI HR1.03, and weaker rectal associations. The number is correctly attributable to this paper, but it does not directly verify the registered before50 endpoint or a proximal-only causal mechanism.",
      "original_source": "https://pubmed.ncbi.nlm.nih.gov/41422343/",
      "source_examination_receipts": [
        "deliverables\\hsef_v53_traffic_ranks_11_15_2026-10-13\\adiposity-early-colorectal-cancer\\examinations\\original-0-10-10000.json"
      ],
      "body_receipts": [
        "deliverables\\hsef_v53_traffic_ranks_11_15_2026-10-13\\adiposity-early-colorectal-cancer\\body-presentation-receipts\\41422343-s1-p0-2-4-5-6.json",
        "deliverables\\hsef_v53_traffic_ranks_11_15_2026-10-13\\adiposity-early-colorectal-cancer\\body-presentation-receipts\\41422343-s2-p0-3-4.json"
      ]
    },
    {
      "pmid": "34914944",
      "doi": "10.1053/j.gastro.2021.12.239",
      "source_type": "primary study report",
      "study_group": "PMID34914944",
      "access_depth": "abstract_metadata",
      "consensus_aspect": "Case-control odds versus prospective hazard and age scope",
      "result_comparison": "Consensus describes timed BMI-at20 and30 estimates of2.56 and2.06 as hazard-level elevations. The original German study is a retrospective population-based case-control analysis using logistic regression and odds ratios, with cases younger than55 and recalled earlier weight. These estimates are neither prospective hazards nor strictly before50 cancer outcomes.",
      "original_source": "https://pubmed.ncbi.nlm.nih.gov/34914944/",
      "source_examination_receipts": [
        "deliverables\\hsef_v53_traffic_ranks_11_15_2026-10-13\\adiposity-early-colorectal-cancer\\examinations\\original-39-49-10000.json"
      ],
      "body_receipts": []
    },
    {
      "pmid": "33327948",
      "doi": "10.1186/s12916-020-01855-9",
      "source_type": "primary study report",
      "study_group": "PMID33327948",
      "access_depth": "full_text_partial",
      "consensus_aspect": "Broader MR versus timed early-onset causal identification",
      "result_comparison": "Consensus recognizes that traditional BMI instruments describe lifelong exposure, but its opening asserts that prospective and genetic analyses demonstrate the before50 proposition. Original MR Methods use overall and site-specific CRC outcome consortia without a before50 estimate; IVW and weighted-median positives coexist with heterogeneity and imprecise alternative estimators. This strengthens the broader causal link under assumptions while leaving age and timed-exposure transfer explicit.",
      "original_source": "https://pubmed.ncbi.nlm.nih.gov/33327948/",
      "source_examination_receipts": [
        "deliverables\\hsef_v53_traffic_ranks_11_15_2026-10-13\\adiposity-early-colorectal-cancer\\examinations\\original-20-30-10000.json"
      ],
      "body_receipts": [
        "deliverables\\hsef_v53_traffic_ranks_11_15_2026-10-13\\adiposity-early-colorectal-cancer\\body-presentation-receipts\\33327948-s1-p0-1-2-4-5-7.json",
        "deliverables\\hsef_v53_traffic_ranks_11_15_2026-10-13\\adiposity-early-colorectal-cancer\\body-presentation-receipts\\33327948-s2-p0-2-8.json"
      ]
    },
    {
      "pmid": "30326010",
      "doi": "10.1001/jamaoncol.2018.4280",
      "source_type": "primary study report",
      "study_group": "NHSII",
      "access_depth": "abstract_metadata",
      "consensus_aspect": "Direct prospective association and effect-size range",
      "result_comparison": "Consensus presents obesity associations around1.5-1.9 as consistent prospective evidence. The original NHSII report provides a directly before50 endpoint:114 cancers in85256 women, obesity RR1.93 versus a lean-reference range and a BMI risk gradient. It is an observational female cohort with a linked disclosure correction, not a genetic or randomized exposure experiment and not proof of uniform effects across sex and site.",
      "original_source": "https://pubmed.ncbi.nlm.nih.gov/30326010/",
      "source_examination_receipts": [
        "deliverables\\hsef_v53_traffic_ranks_11_15_2026-10-13\\adiposity-early-colorectal-cancer\\examinations\\original-0-10-10000.json"
      ],
      "body_receipts": []
    },
    {
      "pmid": "40971243",
      "doi": "10.1158/1055-9965.EPI-25-0400",
      "source_type": "primary study report",
      "study_group": "PMID40971243",
      "access_depth": "abstract_metadata",
      "consensus_aspect": "Majority of incidence growth claim",
      "result_comparison": "Consensus categorically states adiposity does not explain most incidence growth, largely citing reviews and site patterns. The Korean original computes local BMI-attributable fractions around ten percent under causal assumptions, while its outcome and exposure prevalence are specific to that cohort. This is informative but does not establish a global decomposition or disprove a majority contribution everywhere. The review therefore says a majority-growth claim is unestablished, rather than presenting its negation as proved.",
      "original_source": "https://pubmed.ncbi.nlm.nih.gov/40971243/",
      "source_examination_receipts": [
        "deliverables\\hsef_v53_traffic_ranks_11_15_2026-10-13\\adiposity-early-colorectal-cancer\\examinations\\original-10-20-10000.json"
      ],
      "body_receipts": []
    },
    {
      "pmid": "42610385",
      "doi": "10.1097/DCR.0000000000004351",
      "source_type": "primary study report",
      "study_group": "PMID42610385",
      "access_depth": "abstract_metadata",
      "consensus_aspect": "Consistency, age interaction and population growth",
      "result_comparison": "Consensus emphasizes a consistent adiposity relationship but did not visibly incorporate the requested AllofUs counterpoint. That original found no age-specific BMI effect in a retrospective matched sample. Lack of age interaction is not a zero overall causal effect and does not by itself explain incidence trends; it is retained as a scope and precision boundary.",
      "original_source": "https://pubmed.ncbi.nlm.nih.gov/42610385/",
      "source_examination_receipts": [
        "deliverables\\hsef_v53_traffic_ranks_11_15_2026-10-13\\adiposity-early-colorectal-cancer\\examinations\\original-10-20-10000.json"
      ],
      "body_receipts": []
    },
    {
      "pmid": "27978560",
      "doi": "10.1001/jamaoncol.2016.5194",
      "source_type": "primary study report",
      "study_group": "PMID27978560",
      "access_depth": "abstract_metadata",
      "consensus_aspect": "Inherited syndromes versus all susceptibility variants",
      "result_comparison": "Consensus gives a broad inherited-syndrome range, mentioning Lynch syndrome. The unselected original finds pathogenic susceptibility variants in16percent of450 cases, spanning Lynch, APC, MUTYH and other genes. These categories must not be collapsed into a Lynch-only percentage or treated as a population attributable fraction for incidence growth.",
      "original_source": "https://pubmed.ncbi.nlm.nih.gov/27978560/",
      "source_examination_receipts": [
        "deliverables\\hsef_v53_traffic_ranks_11_15_2026-10-13\\adiposity-early-colorectal-cancer\\examinations\\original-49-60-10000.json"
      ],
      "body_receipts": []
    },
    {
      "pmid": "40267983",
      "doi": "10.1038/s41586-025-09025-8",
      "source_type": "primary study report",
      "study_group": "PMID40267983",
      "access_depth": "full_text_partial",
      "consensus_aspect": "Microbial aspect, mutational timing and provider omissions",
      "result_comparison": "Consensus describes microbial/antibiotic exposures as investigational but gives no visible original colibactin source detail in its response. The examined original publisher Methods/Results distinguish historical mutation signatures from current pks-positive bacteria and infer early clonal timing from tumor evolution. This supports a specific organism-genotoxin mechanism more strongly than generic dysbiosis, without establishing universal microbial causation or a directly measured childhood infection date.",
      "original_source": "https://pubmed.ncbi.nlm.nih.gov/40267983/",
      "source_examination_receipts": [
        "deliverables\\hsef_v53_traffic_ranks_11_15_2026-10-13\\adiposity-early-colorectal-cancer\\examinations\\original-49-60-10000.json"
      ],
      "body_receipts": [
        "deliverables\\hsef_v53_traffic_ranks_11_15_2026-10-13\\adiposity-early-colorectal-cancer\\body-presentation-receipts\\40267983-publisher-selected-reviewer-notes.json"
      ]
    }
  ],
  "grade_changed": false,
  "grade_change_note": "Source-based adjudication; no independent blinded regrade claimed.",
  "raw_receipts": [
    {
      "path": "deliverables\\hsef_v53_traffic_ranks_11_15_2026-10-13\\adiposity-early-colorectal-cancer\\consensus-browser-2026-10-13.json",
      "sha256": "fe5186ae869fa8fbd024fea482f199c82001b8f903a7effa8e19e21a5cb773ea"
    }
  ],
  "independent_blinded_audit": false,
  "cutoff": "2026-10-13",
  "completed_utc": "2026-10-13T17:02:52.474755+00:00",
  "conclusion": "Endpoint hierarchy, experimental scope and original-source limits determine the evidence cards; provider wording does not override them."
}
